Skip to main content
. 2020 Dec 31;71(1):34–42. doi: 10.1136/gutjnl-2020-322339

Figure 2.

Figure 2

Trial profile. Flow chart of screened, randomised and treated patients. FL-IFX, first-line infliximab treatment.